Table 7.

Univariate and multivariate associations between product effectiveness and the changes in blood biomarkers.

Covariates	Univariate		Multivariate
	OR (95% CI)	p-value	OR (95% CI)	p-value
Blood ammonia	1.001 (0.984–1.019)	0.8654	0.999 (0.980–1.018)	0.9272
Blood glucose	3.021 (1.378–6.624)	0.0058	3.062 (1.349–6.951)	0.0075
Free fatty acid	1.000 (0.998–1.002)	0.8537	1.000 (0.998–1.002)	0.8503
Creatine kinase	1.002 (0.988–1.017)	0.7376	1.006 (0.991–1.021)	0.4467
C-reactive protein	0.846 (0.610–1.175)	0.3173	0.825 (0.582–1.171)	0.2820
Blood lactic acid	0.313 (0.136–0.717)	0.0061	0.334 (0.144–0.776)	0.0108
Estradiol (female)	1.001 (0.994–1.007)	0.8276	N/A	N/A
Testosterone (male)	1.188 (0.801–1.764)	0.3916	N/A	N/A

Logistic regression was used to evaluate the associations between product effectiveness (remission and relief) and the changes in blood biomarkers after the intervention. OR, odds ratio; CI, confidence interval; N/A, not applicable. Numbers in bold indicate statistical significance.